Composition for treating osteoporosis and hormonal imbalance

Details Composition for treating osteoporosis and hormonal imbalance Composition for treating osteoporosis and hormonal imbalance

A - Human Necessities

61

K

A61K 31/56 (2006.01) A61K 9/20 (2006.01) A61K 33/16 (2006.01) A61K 33/42 (2006.01)

Patent

CA 2041799

COMPOSITION FOR TREATING OSTEOPOROSIS AND HORMONAL IMBALANCE ABSTRACT OF THE DISCLOSURE A medication for providing fluoride ion for the prevention and treatment of bone loss disease, together with an estrogen-containing substance for not only treating hormonal imbalance but to obtain more advantageous use of the fluoride ion within the body. The dosage is a lozenge, tablet or capsule containing from 20 to 100 milligrams of sodium monofluorophosphate and further including an estrogen-containing substance and a slow release mechanism for controlling release of the fluoride ion and estrogen over a period of from four to eight hours after swallowing. Up to ten percent of sodium fluoride and/or calcium can be added.

Affiliated with

Also associated with

Rating

Composition for treating osteoporosis and hormonal imbalance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for treating osteoporosis and hormonal imbalance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating osteoporosis and hormonal imbalance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1796988